reference/8916377

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8916377

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, U.S. Gov't, Non-P.H.S.
issn	2212-8778
pageRange	101347-
publicationName	Molecular Metabolism
startingPage	101347
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_cf5b9d5995507abc870f68cd20a978d7 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c81c82b4ad9caa060230b3c9689699b7 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_916de93fe8f49855f42e16db43537393 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_77e2488754b2b37f99f84e3d30d28ece http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_fa692fa31ab7b0a951b395b4718a6684 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_eb4f340a1767b2ff28113b9d3c67834b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_2e40ee3fb9751a773bdcbb8c387ca09b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c76a33173c1e538af6e1d67717a72ad7 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_6a06f795e2776f8b4caa4cc13fa47f47
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_193e251b256577b626ac3d41baf47f72 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_61651c737bc0dc938f577a06850abbb7 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ced66acda178dc60e237477bf27a208f http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e290b3fcd9a7f0cc0d2d0ad74ae52589 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f1c2cc985d276d3d6e157ba4f63f87f2 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2c91d8aa023f06712ff25b78c179406d http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1fe69d0eed09c2b19f4d8e21f619c4f4 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a533f0c4e63db02c7e624eb595bac6c7 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_6fac77ec8b853b8acf9cf537775fff1a http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_df11db81e76b7fc42579941843600b71 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d72e2df7d06a676196cf87b0c865c794 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_185cab4ad0fbbb4bafc19b952257db7a
bibliographicCitation	Bosma KJ, Andrei SR, Katz LS, Smith AA, Dunn JC, Ricciardi VF, Ramirez MA, Baumel-Alterzon S, Pace WA, Carroll DT, Overway EM, Wolf EM, Kimple ME, Sheng Q, Scott DK, Breyer RM, Gannon M. Pharmacological blockade of the EP3 prostaglandin E2 receptor in the setting of type 2 diabetes enhances β-cell proliferation and identity and relieves oxidative damage. Molecular Metabolism. 2021 Dec;54():101347. doi: 10.1016/j.molmet.2021.101347.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1877-3725 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3097-0767 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d339c1efdcadf3253d14fa751be9df67 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7815-8698 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0869-9699 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3266-3824 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5283-4707 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5828-4403 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7895-8559 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_746a320dcad5212c2b5c8684bd0b24ee http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9644-5765 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e305c8edc7df44654c36444aadb90844 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0011-2112 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3287-8101 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6982-3097 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1221-1169 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4189-4920
date	202112
identifier	https://doi.org/10.1016/j.molmet.2021.101347 https://pubmed.ncbi.nlm.nih.gov/PMC8529552 https://pubmed.ncbi.nlm.nih.gov/34626853
isPartOf	https://portal.issn.org/resource/ISSN/2212-8778 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/41294
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Pharmacological blockade of the EP3 prostaglandin E2 receptor in the setting of type 2 diabetes enhances β-cell proliferation and identity and relieves oxidative damage
discusses	http://id.nlm.nih.gov/mesh/M0541788
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D003924Q000188 http://id.nlm.nih.gov/mesh/D058308Q000037 http://id.nlm.nih.gov/mesh/D050417Q000187
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D008820 http://id.nlm.nih.gov/mesh/D049109Q000187 http://id.nlm.nih.gov/mesh/D018384Q000187 http://id.nlm.nih.gov/mesh/D003924Q000473 http://id.nlm.nih.gov/mesh/D008810 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D050417Q000378 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D058308Q000378 http://id.nlm.nih.gov/mesh/D003924Q000378
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6f4481c466d916e8aab13a1043e44412 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d9bca06a35a8cad0cb73f0fd7674c7e4 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8072 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280360 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_578ac5b806c2a4d1ea12f98b90c1b307 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_195d82ce0f37600d4e0197c9a0c33d49 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5b849ab609b448374c078d5af0cf4f2c http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7444 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8173 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7440 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f56a221bc770a5fa884ac7d3634f29a8 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_92857b9892aee13197962660c7833c38 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_138775485fdba2c6ac08e30274fae50a http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8d8efb5335a904318b9014eccec9d3e9

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID19218 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID16847

Total number of triples: 86.